Clinical Trials Logo
  1. Home
  2. Peripheral Arterial Disease
  3. NCT01094678
  4. Details
NCT01094678 Clinical Trial

Zilver® PTX™ Global Registry

Peripheral Arterial Disease Clinical Trial

Official title:
Evaluation of the Safety and Performance of the Zilver® PTX™ Drug-Eluting Stent for Treating De Novo or Restenotic Lesions of the Above-the-knee Femoropopliteal Artery

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01094678
Other study ID # 05-518
Secondary ID 100010
Status Completed
Phase N/A
First received March 25, 2010
Last updated September 9, 2014
Start date April 2006
Est. completion date April 2011

Study information
Verified date September 2014
Source Cook
Contact n/a
Is FDA regulated No
Health authority Germany: German Institute of Medical Documentation and InformationKorea: Food and Drug AdministrationItaly: Ministry of HealthCanada: Health CanadaCzech Republic: State Institute for Drug ControlSpain: Agencia Española de Medicamentos y Productos SanitariosFrance: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)Switzerland: SwissmedicSweden: Medical Products AgencyPoland: Ministry of HealthNetherlands: Dutch Health Care InspectorateBelgium: The Federal Public Service (FPS) Health, Food Chain Safety and Environment
Study type Interventional

Clinical Trial Summary

The Zilver PTX Registry Study is a prospective, non-randomized, open-label, multicenter single-arm study enrolling patients in Europe, Asia, and North America with de novo or restenotic (including in-stent restenosis) lesions of the above-the-knee femoropopliteal artery (SFA). The primary endpoint of the study is event-free survival (EFS) at 6 months.

Recruitment information / eligibility
Status Completed
Enrollment 788
Est. completion date April 2011
Est. primary completion date January 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- stenosis of the above-the-knee femoropopliteal artery

- appropriate size and location of the lesion

Exclusion Criteria:

- pregnant or breast feeding

- failure or inability to give informed consent

- simultaneously participating in another drug or device study

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Device:
• Zilver® PTX™ Stent
Stenting of the superfemoropopliteal artery.

Locations
Country Name City State
Germany Heart Center Leipzig, Angiology Leipzig
Germany St. Franziskus Hospital Munster Munster
Germany Universitat Klinik Tubingen Tubingen
Italy University of Roma La Sapienza Rome

Sponsors (1)
Lead Sponsor Collaborator
Cook

Countries where clinical trial is conducted

Germany,  Italy, 

Outcome
Type Measure Description Time frame Safety issue
Primary Event-free Survival 6 months Yes
See also
  Status Clinical Trial Phase
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Active, not recruiting NCT03987061 - MOTIV Bioresorbable Scaffold in BTK Artery Disease N/A
Recruiting NCT03506633 - Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients N/A
Active, not recruiting NCT03506646 - Dietary Nitrate Supplementation and Thermoregulation N/A
Active, not recruiting NCT04677725 - NEtwork to Control ATherothrombosis (NEAT Registry)
Recruiting NCT05961943 - RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients N/A
Recruiting NCT06047002 - Personalised Antiplatelet Therapy for Patients With Symptomatic Peripheral Arterial Disease
Completed NCT03185052 - Feasibility of Outpatient Care After Manual Compression in Patients Treated for Peripheral Arterial Disease by Endovascular Technique With 5F Sheath Femoral Approach N/A
Recruiting NCT05992896 - A Study of Loco-Regional Liposomal Bupivacaine Injection Phase 4
Completed NCT04635501 - AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial N/A
Recruiting NCT04584632 - The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery N/A
Withdrawn NCT03994185 - The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease N/A
Withdrawn NCT03538392 - Serranator® Alto Post Market Clinical Follow Up (PMCF) Study
Recruiting NCT02915796 - Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty Phase 1
Active, not recruiting NCT02900924 - Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D
Completed NCT02901847 - To Evaluate the Introduction of a Public Health Approach to Peripheral Arterial Disease (PAD) Using National Centre for Sport and Exercise Medicine Facilities. N/A
Not yet recruiting NCT02387450 - Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication Phase 2/Phase 3
Not yet recruiting NCT02455726 - Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease N/A
Withdrawn NCT02126540 - Trial of Pantheris System, an Atherectomy Device That Provides Imaging While Removing Plaque in Lower Extremity Arteries N/A
Completed NCT02022423 - Physical Activity Daily - An Internet-Based Walking Program for Patients With Peripheral Arterial Disease N/A